Cargando…
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC) associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced immunity. Here we compared humoral and cellular responses against SARS-CoV-2 VOC in subjects immunized with the DNA vaccin...
Autores principales: | Andrade, Viviane M., Christensen-Quick, Aaron, Agnes, Joseph, Tur, Jared, Reed, Charles, Kalia, Richa, Marrero, Idania, Elwood, Dustin, Schultheis, Katherine, Purwar, Mansi, Reuschel, Emma, McMullan, Trevor, Pezzoli, Patrick, Kraynyak, Kim, Sylvester, Albert, Mammen, Mammen P., Tebas, Pablo, Joseph Kim, J., Weiner, David B., Smith, Trevor R. F., Ramos, Stephanie J., Humeau, Laurent M., Boyer, Jean D., Broderick, Kate E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516974/ https://www.ncbi.nlm.nih.gov/pubmed/34650089 http://dx.doi.org/10.1038/s41541-021-00384-7 |
Ejemplares similares
-
578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants
por: Andrade, Viviane M, et al.
Publicado: (2021) -
571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster
por: Tebas, Pablo, et al.
Publicado: (2021) -
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
por: Tebas, Pablo, et al.
Publicado: (2020) -
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
por: Walters, Jewell N., et al.
Publicado: (2022) -
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
por: Vonderheide, Robert H, et al.
Publicado: (2021)